JP2016537995A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016537995A5 JP2016537995A5 JP2016551046A JP2016551046A JP2016537995A5 JP 2016537995 A5 JP2016537995 A5 JP 2016537995A5 JP 2016551046 A JP2016551046 A JP 2016551046A JP 2016551046 A JP2016551046 A JP 2016551046A JP 2016537995 A5 JP2016537995 A5 JP 2016537995A5
- Authority
- JP
- Japan
- Prior art keywords
- vector
- protein
- nucleic acid
- acid sequence
- sequence encoding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019124435A JP7423206B2 (ja) | 2013-11-05 | 2019-07-03 | 新しいアルツハイマー病動物モデル |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13306518.5 | 2013-11-05 | ||
| EP13306518 | 2013-11-05 | ||
| PCT/EP2014/073838 WO2015067668A1 (en) | 2013-11-05 | 2014-11-05 | New alzheimer's disease animal model |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019124435A Division JP7423206B2 (ja) | 2013-11-05 | 2019-07-03 | 新しいアルツハイマー病動物モデル |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016537995A JP2016537995A (ja) | 2016-12-08 |
| JP2016537995A5 true JP2016537995A5 (enExample) | 2017-10-19 |
Family
ID=49619855
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016551046A Pending JP2016537995A (ja) | 2013-11-05 | 2014-11-05 | 新しいアルツハイマー病動物モデル |
| JP2019124435A Active JP7423206B2 (ja) | 2013-11-05 | 2019-07-03 | 新しいアルツハイマー病動物モデル |
| JP2022007713A Pending JP2022084573A (ja) | 2013-11-05 | 2022-01-21 | 新しいアルツハイマー病動物モデル |
| JP2023177383A Withdrawn JP2024009964A (ja) | 2013-11-05 | 2023-10-13 | 新しいアルツハイマー病動物モデル |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019124435A Active JP7423206B2 (ja) | 2013-11-05 | 2019-07-03 | 新しいアルツハイマー病動物モデル |
| JP2022007713A Pending JP2022084573A (ja) | 2013-11-05 | 2022-01-21 | 新しいアルツハイマー病動物モデル |
| JP2023177383A Withdrawn JP2024009964A (ja) | 2013-11-05 | 2023-10-13 | 新しいアルツハイマー病動物モデル |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US10159227B2 (enExample) |
| EP (1) | EP3066203B2 (enExample) |
| JP (4) | JP2016537995A (enExample) |
| WO (1) | WO2015067668A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107737138B (zh) * | 2017-11-29 | 2020-09-18 | 宁夏医科大学 | 一种环境污染物对记忆损害动物模型的建立方法 |
| US20220133808A1 (en) * | 2019-02-01 | 2022-05-05 | Avrobio, Inc. | Compositions and methods for treating neurocognitive disorders |
| JP2023505008A (ja) | 2019-10-28 | 2023-02-08 | エージェント | アルツハイマー病の無症状期を診断するためのバイオマーカーおよびその使用 |
| KR20230009140A (ko) * | 2021-07-08 | 2023-01-17 | 주식회사 엠케이바이오텍 | Human mutant Presenilin-1 발현 인지장애 모델 개의 생산 |
| CN113957095A (zh) * | 2021-10-22 | 2022-01-21 | 江苏集萃药康生物科技股份有限公司 | 一种用于构建阿尔兹海默症动物模型的构建方法及其核酸组合物和应用 |
| CN114672462B (zh) * | 2022-03-10 | 2023-10-20 | 中山大学·深圳 | 阿尔茨海默病模型及其建立方法和用途 |
| CN115354048B (zh) * | 2022-06-08 | 2024-02-02 | 暨南大学 | 阿尔茨海默病动物模型的构建方法、用途和Aβ42重组表达载体 |
| CN116716351B (zh) * | 2023-03-30 | 2024-02-23 | 湖北天勤生物技术研究院有限公司 | 用于构建食蟹猴阿尔兹海默症模型的组合物及其应用和构建方法 |
| AU2024285988A1 (en) * | 2023-06-08 | 2025-11-20 | Regeneron Pharmaceuticals, Inc. | Animal model with rapid onset of alzheimer's amyloid beta plaque pathology |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US4861719A (en) | 1986-04-25 | 1989-08-29 | Fred Hutchinson Cancer Research Center | DNA constructs for retrovirus packaging cell lines |
| US5278056A (en) | 1988-02-05 | 1994-01-11 | The Trustees Of Columbia University In The City Of New York | Retroviral packaging cell lines and process of using same |
| US5670488A (en) | 1992-12-03 | 1997-09-23 | Genzyme Corporation | Adenovirus vector for gene therapy |
| AU8200191A (en) | 1990-07-09 | 1992-02-04 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | High efficiency packaging of mutant adeno-associated virus using amber suppressions |
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| WO1993003769A1 (en) | 1991-08-20 | 1993-03-04 | THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTEMENT OF HEALTH AND HUMAN SERVICES | Adenovirus mediated transfer of genes to the gastrointestinal tract |
| DE69434860T2 (de) | 1993-02-22 | 2007-03-15 | The Rockefeller University | Herstellung von helfer-freien retroviren mit hohem titer mittels transienter transfektion |
| FR2712812B1 (fr) | 1993-11-23 | 1996-02-09 | Centre Nat Rech Scient | Composition pour la production de produits thérapeutiques in vivo. |
| IL116816A (en) | 1995-01-20 | 2003-05-29 | Rhone Poulenc Rorer Sa | Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof |
| US6013516A (en) | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
| JP2003509071A (ja) * | 1999-09-17 | 2003-03-11 | アバンテイス・フアルマ・エス・アー | アミロイド斑およびミトコンドリア機能障害を示すアルツハイマー病の新規の動物モデル |
| US7098374B2 (en) | 2001-02-09 | 2006-08-29 | University Of Florida Research Foundation, Inc. | Human disease modeling using somatic gene transfer |
| US9132173B2 (en) | 2010-10-15 | 2015-09-15 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Expression vector for cholesterol 24-hydrolase in therapy of Huntington's disease |
-
2014
- 2014-11-05 WO PCT/EP2014/073838 patent/WO2015067668A1/en not_active Ceased
- 2014-11-05 JP JP2016551046A patent/JP2016537995A/ja active Pending
- 2014-11-05 US US15/034,370 patent/US10159227B2/en active Active
- 2014-11-05 EP EP14793193.5A patent/EP3066203B2/en active Active
-
2018
- 2018-11-02 US US16/178,949 patent/US10986821B2/en active Active
-
2019
- 2019-07-03 JP JP2019124435A patent/JP7423206B2/ja active Active
-
2022
- 2022-01-21 JP JP2022007713A patent/JP2022084573A/ja active Pending
-
2023
- 2023-10-13 JP JP2023177383A patent/JP2024009964A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wilkinson et al. | Zebrafish as a model of cardiac disease | |
| EP3562514A4 (en) | GENE THERAPY FOR THE TREATMENT OF WILSON'S DISEASE | |
| EA201692359A1 (ru) | Композиция на основе нового штамма prrsv или его белков, продукт, их применение, вирус prrsv, выделенная нк и рекомбинантный вектор экспрессии для получения этого вируса | |
| MX2022010959A (es) | Terapia genica para trastornos oculares. | |
| BR112015023267A2 (pt) | composto | |
| EA202193164A1 (ru) | Гаплоидный индуктор | |
| UA105046C2 (uk) | Пестицидний ген axmi-205 та його використання для захисту рослин від комах-шкідників | |
| CL2017000053A1 (es) | Anticuerpos de unión a protofibrillas aß | |
| EA201300137A1 (ru) | Комбинированная фармацевтическая композиция и способ лечения заболеваний или состояний, связанных с нейродегенеративными зоболеваниями | |
| EA201600476A1 (ru) | Вариант вируса ppcc, клон кднк вируса ppcc европейского типа и их применение | |
| EA201790519A1 (ru) | Терапевтические соединения в качестве ингибиторов рецептора орексина-1 | |
| UA107836C2 (uk) | Метод лікування хвороби альцгеймера | |
| CL2017000382A1 (es) | Compuestos bicíclicos sustituidos | |
| WO2012116196A3 (en) | Substituted lactosyl compounds and use thereof for cellular imaging and therapy | |
| EA201991702A1 (ru) | Самосборные белковые наночастицы, инкапсулирующие иммуностимулирующие нуклеиновые кислоты | |
| RU2016133188A (ru) | Кодон-оптимизированная нуклеотидная последовательность, кодирующая mg53, ее рекомбинанты и их применение | |
| MX2015016882A (es) | Vacuna semi-viva del virus respiratorio sincitial. | |
| LT3413870T (lt) | Igmesinas, skirtas panaudoti alzheimerio ligos gydymui | |
| EP4240389A4 (en) | VIRAL VECTORS ENCODING DOG INSULIN FOR THE TREATMENT OF METABOLIC DISEASES IN DOGS | |
| EP4227685A3 (en) | Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus | |
| JP2013147495A5 (enExample) | ||
| JP2015129652A5 (enExample) | ||
| EA201592299A1 (ru) | Полуживая вирусная вакцина против респираторно-синцитиального вируса | |
| EP3589305C0 (en) | SPECIFIC INCREASE IN DOPAMINE SYNTHESIS BY TARGETING THE GUANYLATE CYCLASE 2C RECEPTOR IN THE TREATMENT OF PARKINSON'S DISEASE | |
| Dyer et al. | Molecular basis of cardiac development |